Molecular Basis of Inherited Factor XIII- A Deficiency among Patients from Sistan - Baluchestan

Author(s):
gholamhossein tamaddongholamhossein tamaddon1,*, Ahmad KazemiAhmad Kazemi2, Ghasem RastgarlariGhasem Rastgarlari3, Fereidoon AlaFereidoon Ala4, Shabnam HejaziShabnam Hejazi4
1MSc of Hematology‚ Dept of Laboratory Sciences, Faculty of Paramedical Sciences, Zahedan University of Medical Sciences and Health Services, Zahedan, Iran.
2Associate Prof, Dept of Hematology, Faculty of Paramedical Sciences, Iran University of Medical Sciences and Health Services, Tehran, Iran.
3Assistant Prof, Dept of Hematology, Faculty of Paramedical Sciences, Iran University of Medical Sciences and Health Services, Tehran, Iran.
4Clinic of Hemophilia, Tehran, Iran.
*Corresponding Author: MSc of Hematology‚ Dept of Laboratory Sciences, Faculty of Paramedical Sciences, Zahedan University of Medical Sciences and Health Services, Zahedan, Iran. Email: [email protected]

Zahedan Journal of Research in Medical Sciences:Vol. 11, issue 4; e94357
Published online:Nov 19, 2009
Article type:Research Article
Received:Mar 03, 2009
Accepted:Sep 30, 2009
How to Cite:tamaddon G, Kazemi A, Rastgarlari G, Ala F, Hejazi S. Molecular Basis of Inherited Factor XIII- A Deficiency among Patients from Sistan - Baluchestan. Zahedan J Res Med Sci. 2010;11(4):e94357. doi:

Abstract

Background : Factor ХШ, the last zymogene in the clotting cascade, converts the loose fibrin polymer into a firm polymer. In the absence of factor ХШ the abnormal fibrin is soluble in acetic acid, as well as 5M urea. Factor ХШ is composed of 2 catalytic A subunit bounds and 2 B subunits as carriers (A2B2). The gene of A chain is located on chromosome 6. Factor ХШ deficiency is rare with a prevalence of only 1 in 2 million in the general population. The overwhelming majority of cases are due to mutations in subunit A. The aim of this study was to detect the mutations of subunit A.

  Materials & m ethods: In this study we investigated the molecular basis of inherited factor ХШ deficiency among 10 unrelated patients from Sistan and Balouchestan province in 2006. Mutations were detected by amplifying each exon. Those exons exhibiting the presence of heteroduplex by conformation sensitive gel electrophoresis (CSGE) were selected for direct sequencing. Sequencing of mutations was carried out by restriction fragment length polymorphism (RFLP).

  Results : All patients had homologous subsitiation of TGG to CGG in exon 4 which led to change of arginine to tryptophan.

  Conclusion : The mutation found in this study was in the core domain of enzyme. It seems that the changs in electric charge and affinity of enzyme to substrate‚as a result decreases the level of factor XIII-A activity.

Fulltext

 The full text of this article is available on the PDF file.

References

  • 1.
    The References of this article are available on the PDF file.

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

22
Dec
2015

Coagulation Factor XIII-A A614T gene Variation is Suggestive of Founder Effect in Iranian Patients with Severe Congenital Factor XIII Deficiency

Majid Naderi,
Shadi Tabibian,
Shaban Alizade,
Zahra Sadat Abtahi,
Akbar Dorgalaleh

Naderi M, Tabibian S, Alizade S, Abtahi ZS, Dorgalaleh A. Coagulation Factor XIII-A A614T gene Variation is Suggestive of Founder Effect in Iranian Patients with Severe Congenital Factor XIII Deficiency. J Cell Mol Anesth. 2016;1(1):e150242. doi: https://doi.org/10.22037/jcma.v1i1.10638

10
Mar
2014

Unusual Prevalence of c559T > C Mutation in Patients with Factor XIII deficiency in Southeast of Iran

Ebrahim Miri-Moghaddam,
Yasaman Garmie,
Majid Naderi

Miri-Moghaddam E, Garmie Y, Naderi M. Unusual Prevalence of c559T > C Mutation in Patients with Factor XIII deficiency in Southeast of Iran. Gene Cell Tissue. 2014;1(1):e18314. doi: https://doi.org/10.17795/gct-18314

26
Aug
2016

c.559 T>C as The Most Common Mutation of Factor XIII Deficiency in Iranian Patients is not Restricted to Southeast Iran

Akbar Dorgalaleh,
Shadi Tabibian,
Bijan Varmaghani,
GholamHossein Tamadon,
Hasan Boustani,
Parvin Rahamani
,et al.

Dorgalaleh A, Tabibian S, Varmaghani B, Tamadon G, Boustani H, et al. c.559 T>C as The Most Common Mutation of Factor XIII Deficiency in Iranian Patients is not Restricted to Southeast Iran. J Cell Mol Anesth. 2016;1(4):e149521. doi: https://doi.org/10.22037/jcma.v1i4.13508

7
Aug
2017

Burden of Congenital Factor XIII Deficiency in Iran

Akbar Dorgalaleh

Dorgalaleh A. Burden of Congenital Factor XIII Deficiency in Iran. J Cell Mol Anesth. 2017;2(3):e149544. doi: https://doi.org/10.22037/jcma.v2i3.16263

22
Sep
2020

The Founder Effect? -FXIII Deficiency in Southeast Iran: A Molecular Study Report

Hojat Shahraki,
Akbar Dorgalaleh,
Majid Fathi,
Shadi Tabibian,
Shahram Teimourian,
Hasan Mollanoori
,et al.

Shahraki H, Dorgalaleh A, Fathi M, Tabibian S, Teimourian S, et al. The Founder Effect? -FXIII Deficiency in Southeast Iran: A Molecular Study Report. J Cell Mol Anesth. 2020;5(4):e149647. doi: https://doi.org/10.22037/jcma.v5i4.31852

Download PDF412.01 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles